Zentalis Pharmaceuticals, LLC (52) | Business Finance (10)
Browse by Subcategory
Recent Contracts
-
Release Agreement, dated May 10, 2022, between Zentalis Pharmaceuticals, Inc. and Anthony Y. Sun, M.D
(Filed With SEC on May 16, 2022)
-
Underwriting Agreement, dated May 16, 2022, by and among the Company and Morgan Stanley & Co. LLC, Jefferies LLC and SVB
(Filed With SEC on May 16, 2022)
-
Description of Capital Stock
(Filed With SEC on March 25, 2021)
-
Amended and Restated Investors Rights Agreement, dated as of September 6, 2019, by and among Zentalis Pharmaceuticals, LLC and the investors party thereto
(Filed With SEC on March 6, 2020)
-
Underwriting Agreement, dated June 28, 2021, by and among the Company and Morgan Stanley & Co. LLC, Jefferies LLC and SVB Leerink LLC, as representatives of the several...
(Filed With SEC on July 1, 2021)
-
Release Agreement, dated May
(Filed With SEC on May 15, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on March 30, 2020)
-
2020 Employee Stock Purchase Plan
(Filed With SEC on March 30, 2020)
-
Form of Conversion Restricted Stock Award Agreement for former Class B Common Unit Holders
(Filed With SEC on March 30, 2020)
-
Specimen Common Stock Certificate evidencing the shares of common stock
(Filed With SEC on March 6, 2020)